SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-053184
Filing Date
2019-10-15
Accepted
2019-10-15 17:08:09
Documents
1
Period of Report
2019-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4899
  Complete submission text file 0001209191-19-053184.txt   6356
Mailing Address C/O OUTLOOK THERAPEUTICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address
KENYON LAWRENCE A (Reporting) CIK: 0001230484 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37759 | Film No.: 191151530

Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)